23 June 2026 in Cancer Research
Fusobacterium nucleatum is a key microbial driver of colorectal cancer progression. In this study, we identified an intercellular signaling axis through which F. nucleatum remodels the immune microenvironment. Analysis of 54 clinical colorectal cancer specimens revealed that high intratumoral F. nucleatum load correlated significantly with PD-L1 upregulation in tumor-associated macrophages, diminished CD8+ T-cell cytotoxicity, and poor patient prognosis. Mechanistically, F. nucleatum infection activated NF-κB signaling in colorectal cancer cells to induce the transcription of the long noncoding RNA mitotically associated long noncoding RNA (MANCR), which was selectively packaged into exosomes via the ESCRT-III/ALIX complex and transferred to macrophages. In recipient macrophages, exosomal MANCR interacted with HNRNP U to increase PD-L1 mRNA stability, leading to sustained PD-L1 surface expression. In humanized mouse models, F. nucleatum exposure inhibited CD8+ T-cell infiltration and suppressed granzyme B activity, thereby compromising antitumor immunity and facilitating tumor proliferation and metastasis. These findings demonstrate that F. nucleatum exploits a tumor-derived exosomal long noncoding RNA network to remotely manipulate macrophage plasticity. Therefore, targeting the F. nucleatum/MANCR/PD-L1 axis may represent a viable strategy to overcome immune resistance in the colorectal cancer microenvironment. Significance: Fusobacterium nucleatum exploits tumor-derived exosomal MANCR to stabilize PD-L1 in macrophages, providing a mechanism of bacterial-driven immune evasion and a potential therapeutic target to restore antitumor immunity in colorectal cancer.
21 September 2026 in Communications Biology
Idiopathic pulmonary fibrosis is a progressive, aging-related lung disease in which fibroblast senescence drives scarring, yet what sustains that senescence is unclear. Here we show that injured alveolar epithelial cells and senescent fibroblasts reinforce each other through a self-amplifying circuit. In fibrotic human and mouse lungs, sphingosine kinase 1 is induced selectively in injured epithelium, whereas senescence markers accumulate in fibroblasts. Epithelium-derived sphingosine-1-phosphate engages the receptor S1PR3 on fibroblasts, activates phosphoinositide 3-kinase-AKT-mTOR signaling, suppresses autophagy and drives senescence. Senescent fibroblasts in turn secrete interleukin-6, which activates STAT3 in epithelial cells and reactivates sphingosine kinase 1 transcription, closing the loop. Deleting sphingosine kinase 1 globally, or silencing it selectively in alveolar epithelium, reduces bleomycin-induced fibrosis in mice, as does pharmacological blockade of either the kinase or its receptor. These findings define an epithelial-fibroblast feedback circuit that sustains lung fibrosis and nominate it as a therapeutic target.